Watanabe N, Iwamura T, Shinoda T, Fujita T
Department of Tumor Cell Biology, The Tokyo Metropolitan Institute of Medical Science, Bunkyo-ku, Tokyo, Japan.
EMBO J. 1997 Jun 16;16(12):3609-20. doi: 10.1093/emboj/16.12.3609.
The candidate oncoprotein BCL-3 has been shown to function as a transcriptional co-activator for homodimers of NF-kappaB p50 and p50B. We expressed BCL-3 ectopically in pro-B cell lines and found that these cells exhibited a dramatic increase in nuclear kappaB motif binding activity of p50 homodimers containing BCL-3 in the complex. Co-transfection and in vitro reconstitution experiments revealed that the complex of p50 with its precursor p105 (p50-p105), which was shown to accumulate in the cytoplasm of the pro-B cell lines, is required for induction of DNA binding of p50 homodimers by BCL-3. However, we could see no in vivo or in vitro evidence of a BCL-3-induced increase in proteolytic processing. Instead, BCL-3-mediated reorganization of NFKB1 subunits was demonstrated in vitro. Immunofluorescence staining clearly demonstrated that the transition from cytoplasmic p50-p105 to nuclear p50 homodimers was induced by BCL-3 expression. Thus BCL-3 has versatile functions: cytoplasmic activation of p50 homodimers, their nuclear translocation and, as previously shown, modulation of the transcriptional machinery in the nucleus.
候选癌蛋白BCL-3已被证明可作为NF-κB p50和p50B同二聚体的转录共激活因子。我们在原B细胞系中异位表达BCL-3,发现这些细胞中含有BCL-3的p50同二聚体的核κB基序结合活性显著增加。共转染和体外重组实验表明,p50与其前体p105(p50-p105)的复合物(已证明其在原B细胞系的细胞质中积累)是BCL-3诱导p50同二聚体DNA结合所必需的。然而,我们在体内或体外均未发现BCL-3诱导蛋白水解加工增加的证据。相反,体外实验证明了BCL-3介导的NFKB1亚基的重组。免疫荧光染色清楚地表明,BCL-3的表达诱导了从细胞质p50-p105到核p50同二聚体的转变。因此,BCL-3具有多种功能:激活p50同二聚体的细胞质活性、使其核转位,以及如先前所示,调节细胞核中的转录机制。